Saibriga (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Saibriga (Laos)

Saibriga is a Lao-manufactured generic of brigatinib, produced by BioSpring.LTD. It is supplied as 90 mg tablets in a 30-tablet pack, matching the lead-in and standard 90 mg maintenance dose of the brigatinib regimen. As a second-generation ALK inhibitor generic, Saibriga delivers the same active ingredient as the originator at a lower, out-of-pocket-friendly price.

What Is Saibriga Used For?

Saibriga is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients whose disease has progressed on or who cannot tolerate crizotinib. It is an oral, once-daily monotherapy that is easy to take at home, and it is prescribed only after a genetic test confirms the ALK rearrangement.

How Does Saibriga (Brigatinib) Work?

The brigatinib in Saibriga is a next-generation ALK tyrosine kinase inhibitor that also inhibits ROS1, IGF-1R, and FLT-3. It blocks the growth signals that drive ALK-positive cancer cells and crosses the blood-brain barrier, making it effective against brain metastases. The generic Saibriga carries the same active ingredient and mechanism as the originator at a lower cost.

Indications

Saibriga is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. It is not appropriate for ALK-negative disease and is not indicated for small-cell lung cancer.

Dosage

The recommended regimen is 90 mg once daily for 7 days, then 180 mg once daily if tolerated. The 90 mg tablets in this listing support the lead-in phase and the 90 mg maintenance dose. Take the tablet with or without food and swallow it whole. If a dose is missed or vomited, do not take an extra tablet — continue with the next scheduled dose.

Side Effects

Common adverse reactions include diarrhea, rash, cough, hypertension, fatigue, nausea, muscle pain, and headache. Blood pressure should be monitored during treatment, and diarrhea is generally manageable with supportive care. Interstitial lung disease is rare but serious and requires permanent discontinuation if confirmed.

Storage

Store Saibriga below 30°C in a dry place, in its original container, and out of the reach of children. No refrigeration is required.

Why Choose the GLT?

For uninsured or under-insured patients, a Lao generic such as Saibriga offers a substantial saving over the originator brand, whose Western list price is very high. GLT sources from established manufacturers and provides the documentation required for safe international shipping, helping patients maintain affordable and continuous therapy.

How to Order

To order Saibriga through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Provide the strength, quantity, and destination country, and we will confirm availability, sourcing origin, and delivery terms. We support both institutional purchasers and individual patients.

FAQ

Is Saibriga a generic of Alunbrig? Yes. Saibriga is a Lao-manufactured generic of brigatinib, the active ingredient in Alunbrig, produced by BioSpring.LTD.

What strength does Saibriga come in? This listing is the 90 mg strength in a 30-tablet box, matching the lead-in and standard 90 mg maintenance dose.

Can I buy generic brigatinib online? Generic brigatinib can be purchased through international suppliers such as GLT. Always confirm the supplier's legitimacy and request proper documentation before ordering.

Related Oncology Products

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle